Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, January 16, 2022.
Talis Biomedical Corporation - common stock (NASDAQ:TLIS)
Long-Term Downtrend (-90) - TLIS is in a strong downtrend that is likely to continue. While TLIS is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid TLIS?
MarketClub looks at technical strength and momentum to determine if the timing is right for TLIS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for TLIS
The long-term trend has been DOWN since Feb 17th, 2021 at 23.0100
The intermediate-term trend has been DOWN since Nov 16th, 2021 at 4.8950
The short-term trend has been DOWN since Jan 5th, 2022 at 3.9601
Smart Scan Analysis for TLIS
Based on our trend formula, TLIS is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.17 | 3.28 | 3.14 | 3.24 | +0.07 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.26 | 64260 | 2022-01-14 15:59:57 |
| 52wk High | 33.9 | 52wk High Date | 2021-02-12 |
| 52wk Low | 3.11 | 52wk Low Date | 2022-01-10 |
| Average Volume | 163,900 | Shares Outstanding | 56,152 |
| Assets | 303,096,000M | Liabilities | 44,304,000M |